Compare AOMR & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOMR | CNXU |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.5M | 215.9M |
| IPO Year | 2019 | 2025 |
| Metric | AOMR | CNXU |
|---|---|---|
| Price | $9.03 | $7.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $11.08 | N/A |
| AVG Volume (30 Days) | 89.9K | ★ 132.2K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | ★ 14.18% | N/A |
| EPS Growth | ★ 53.85 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.38 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.96 | $6.85 |
| 52 Week High | $10.14 | $13.66 |
| Indicator | AOMR | CNXU |
|---|---|---|
| Relative Strength Index (RSI) | 54.19 | 43.51 |
| Support Level | $8.72 | $7.55 |
| Resistance Level | $9.24 | $10.35 |
| Average True Range (ATR) | 0.20 | 1.14 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 70.46 | 33.43 |
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in first and second lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rate and credit cycles. The company operates in a single operating segment, which is to acquire, invest in, and finance mortgage-related assets.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.